Chronic treatment with cannabinoid receptor agonist, CP 55,940,
The brain and the immune system Mind over matter ד " ר יוסי רימר.
Refractec ViewPoint™ CK System for the Treatment of Spherical Hyperopia Sheryl Berman, MD Medical Officer FDA/CDRH/ODE/DOED.
Chronic treatment with cannabinoid receptor agonist, CP 55,940, alters GLT1 expression in adolescent rats Introduction Methods Results Selected References.
Facing Climate Changes: Towards Sustainable Planning and Management of Water Resources Prof. Ezio Todini
Presented by Leanne Gravette, Jeff Gibberman, Zoe Fisher-Falk.
Amyloid ß 1-42 -Associated p75 NTR Expression in Human Neuroblastoma Cells and Hippocampal Cells in Murine and Human AD Brains ADI Conference-Toronto March.
